The company highlights role of integrated genomics and multi-omics research at the Illumina Multiomics Summit India 2026 held in New Delhi and Bengaluru
The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways
Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize biomarker testing and enhance precision medicine capabilities
Access to NIPT, TB and Rare Disease diagnostics to benefit thousands of patients nationwide
Coordinated by the Medical University of Vienna, a consortium of 13 leading European organizations including university hospitals, research institutions and healthcare companies will conduct the 5-year project co-funded by Horizon Europe.
Athos will perform multi-omic molecular and genetic analyses using biopsies from archived and de-identified Lahey IBD patient samples
The acquisition positions Roche more aggressively in digital pathology and precision diagnostics capabilities
Precision medicine company advances Raman spectroscopy-based therapeutic drug monitoring platform for rapid, patient-specific dosing solutions
The summit will bring together 1,200+ delegates, 100+ international faculty from 25 countries
Subscribe To Our Newsletter & Stay Updated
